📖 Retrospective cohort study on neighborhood SDOH in MASLD hot off the press! 📖
🚩Patients w/ MASLD living in the most disadvantaged neighborhoods have ⬆️ mortality, liver dz burden, 🫀 disease & T2DM.
Now in @AGA_CGH ! 🔗https://t.co/yoV3emPtzj
Thank you to my mentor @KarnJUVE
Honoured to be part of @KarnJUVE collab on effect of 🏘️in MASH. It was associated with an increase odds of cirrhosis (aOR 1.42), diabetes (aOR 1.57), and hypertension (aOR 1.38), death (aHR 1.47), liver-related events (aHR 1.31), and MACE (aHR 1.24).
https://t.co/Q5RdaXBoiD
That’s a wrap for #TLM24 in San Diego! Great to reconnect with friends, make new connections, and learn from the liver experts. Thank you to @AASLDFoundation for selecting me as an Emerging Liver Scholar! #LiverTwitter@AASLDtweets
Proud of my mentee, Dr. Majd Aboona @MajdAboona being selected as AASLD Emerging Liver Scholar 2024. Majd has done a phenomenal job in clinical and research @UAPhxIM in racial disparity in #MASLD#SLD#ALD. Keep up the great work! #TLM24@AASLDFoundation
Fantastic turn out from the UA Phoenix team at #TLM24. Our amazing residents, fellows, and faculty shared all their hard work and their excitement about the future of hepatology! @UAzMedPhxChair@AASLDtweets@YasminAlishahi 🎓⚕️
Introducing the 2024 Emerging Liver Scholars! 🤩 Huge congrats to Majd Aboona, MD, Hazem Abosheaishaa, MD, MSc, Kareen Akiva, MD, and Mukarram Jamat Ali, MD.
Learn more about AASLD Foundation's 2024 awardees at https://t.co/kVfI2v07mv
Thanks to Dr. @rabataller that highlight our paper in @JGHofficial.
MetALD population significantly increased risk of cancer mortality and need close cancer surveillance.
Great job @MajdAboona who also got @AASLDFoundation Emerging Liver Scholar 2024👏🎉⭐️
1/2
📢New research on #MASLD reveals significant ethnic disparities in outcomes
Hispanic,African, & Native American/Alaskan patients face higher mortality & liver-related events (LREs) than European patients 😔
🔗 https://t.co/fM5xMd4K2s
✍️ @MajdAboona@KarnJUVE#livertwitter
Assembling diverse cohorts is the best way we can learn about drivers of disease progression - whether genetic or social determinants of health
Great presentation by Majd Aboona (@MajdAboona)
@KarnJUVE Vincent Chen (@MichiganLiver)
#easlcongress
🚨Check out our paper in @LiverInt
Racial disparity in MASLD from @BannerHealth cohort🏥
⬆️Prevalence cirrhosis, DM in Hispanic, Native American (NA)
⬆️Mortality, Liver events in Hispanic, NA, and Black
Great job @MajdAboona@ClaireSFaulkner#livertwitter
I had a great opportunity this week to present my research internationally in Vienna at the #EASLCongress!! Very thankful to have supportive mentorship from @KarnJUVE. #GItwitter#LiverTwitter